bpc-157 clinical trial human study and the Difference Between an Evidence Gap and a Cover-Up: What the entire evidence base actually looks like, and the questions to ask next. — WellFounded bpc-157 human clinical trials evidence
Description
Plant-based sources are not as common

Rong, S

roughly 50-98 % of an administered dose is renally excreted unmetabolized, underscoring the low intrinsic toxicity

Ingredients that are on the FDA negative list also cannot be used as active ingredients for human compounding unless a specific route or dose is allowed on the list, as is the case with oral doses of diethylstilbestrol under 25 mg
Probiotics and prebiotics in the management of irritable bowel syndrome: a review of recent clinical trials and systematic reviews

[DOI] [PMC free article] [PubMed] [Google Scholar] 172.Wein MN, Liang Y, Goransson O, Sundberg TB, Wang J, Williams EA, et al
